Sign in

CIK 0000921299

  • Non-accelerated filer
  • Smaller reporting company

KYNTRA BIO, INC.

Sign in to watch
Ticker
KYNB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
770357827
Phone
+1 415-978-1200
Business address
350 BAY STREET, SUITE 100 #6009, SAN FRANCISCO, CA, 94133
Former names
FIBROGEN INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-06-19 Chung Christine SVP, China Operations Exercise or conversion · Stock Option (Right to Buy) −5,625 14,584
2019-06-18 Kouchakji Elias SVP, Clinical Dev, Drug Safety Exercise or conversion +16,000 $14.58 $233K 112,072
2019-06-18 Kouchakji Elias SVP, Clinical Dev, Drug Safety Exercise or conversion · Stock Option (Right to Buy) −16,000 7,082
2019-06-18 Cotroneo Pat SVP, Finance and CFO Sale −3,201 $43.12 $138K 250,777
2019-06-18 Chung Christine SVP, China Operations Exercise or conversion +2,120 $29.66 $63K 157,195
2019-06-18 Chung Christine SVP, China Operations Sale −5,625 $44.08 $248K 151,570
2019-06-18 Chung Christine SVP, China Operations Exercise or conversion · Stock Option (Right to Buy) −2,120 20,209
2019-06-14 Yu K Peony Chief Medical Officer Sale −3,420 $40.96 $140K 186,976
2019-06-12 Yu K Peony Chief Medical Officer Exercise or conversion +10,698 $14.58 $156K 190,396
2019-06-12 Yu K Peony Chief Medical Officer Exercise or conversion · Stock Option (Right to Buy) −10,698 657
2019-06-10 Blaug Suzanne Director Grant or award +4,648 4,648
2019-06-10 Blaug Suzanne Director Grant or award · Stock Option (Right to Buy) +7,714 7,714
2019-06-10 Blaug Suzanne Director Grant or award · Stock Option (Right to Buy) +10,400 10,400
2019-06-06 Yu K Peony Chief Medical Officer Shares withheld for taxes −3,360 $38.31 $129K 179,698
2019-06-06 Neff Thomas B Chief Executive Officer Exercise or conversion +6,834 $2.90 $20K 2,469,214
2019-06-06 Neff Thomas B Chief Executive Officer Sale −6,900 $37.57 $259K 2,462,314
2019-06-06 Neff Thomas B Chief Executive Officer Sale −11,500 $38.16 $439K 2,450,814
2019-06-06 Neff Thomas B Chief Executive Officer Shares withheld for taxes −8,542 $38.31 $327K 2,442,272
2019-06-06 Neff Thomas B Chief Executive Officer Sale −800 $37.77 $30K 59,036
2019-06-06 Neff Thomas B Chief Executive Officer Sale −618 $38.20 $24K 58,418

Page 32 of 33 · 651 trades